Upgrade to SI Premium - Free Trial

Travere Therapeutics (TVTX)

65.28 -1.26 (1.89%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/22/26)

Latest Headlines

Form 4 Travere Therapeutics, For: Aug 17 Filed by: LYONS GARY A August 19, 2026 4:05 PM - SEC Filing Form 144 Travere Therapeutics, Filed by: LYONS GARY A August 18, 2026 4:24 PM - SEC Filing Form 144 Travere Therapeutics, Filed by: LYONS GARY A August 17, 2026 4:32 PM - SEC Filing Travere Therapeutics (TVTX) PT Raised to $68 at Piper Sandler August 17, 2026 7:44 AM - StreetInsider Form SCHEDULE 13G/A Travere Therapeutics, Filed by: ARMISTICE CAPITAL, LLC August 14, 2026 10:29 AM - SEC Filing Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 12, 2026 5:00 PM - BizWire Form SCHEDULE 13G Travere Therapeutics, Filed by: BANK OF AMERICA CORP /DE/ August 12, 2026 1:29 PM - SEC Filing Form SCHEDULE 13G Travere Therapeutics, Filed by: STATE STREET CORP August 7, 2026 11:03 AM - SEC Filing Form SCHEDULE 13G/A Travere Therapeutics, Filed by: FMR LLC August 6, 2026 10:44 AM - SEC Filing Travere Therapeutics (TVTX) PT Raised to $70 at Canaccord August 6, 2026 6:42 AM - StreetInsider Travere Therapeutics (TVTX) PT Raised to $80 at Wells Fargo August 6, 2026 6:38 AM - StreetInsider Travere Therapeutics to Participate at Upcoming Investor Conferences August 5, 2026 4:30 PM - BizWire Travere Therapeutics (TVTX) PT Raised to $75 at Wedbush August 5, 2026 9:55 AM - StreetInsider Travere Therapeutics (TVTX) PT Raised to $62 at Stifel August 5, 2026 8:25 AM - StreetInsider Travere Therapeutics (TVTX) PT Raised to $75 at TD Cowen August 5, 2026 8:15 AM - StreetInsider Travere Therapeutics (TVTX) PT Raised to $85 at Citi August 5, 2026 4:56 AM - StreetInsider Travere Therapeutics (TVTX) Misses Q2 EPS by 2c August 5, 2026 12:47 AM - StreetInsider Form 10-Q Travere Therapeutics, For: Jun 30 August 4, 2026 4:46 PM - SEC Filing Form 8-K Travere Therapeutics, For: Aug 04 August 4, 2026 4:06 PM - SEC Filing Travere Therapeutics Reports Second Quarter 2026 Financial Results August 4, 2026 4:01 PM - BizWire Travere Therapeutics (TVTX) PT Raised to $62 at Canaccord July 30, 2026 7:21 AM - StreetInsider Travere Therapeutics to Report Second Quarter 2026 Financial Results July 28, 2026 4:30 PM - BizWire Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 10, 2026 5:00 PM - BizWire Form 8-K Travere Therapeutics, For: Jul 06 July 9, 2026 5:10 PM - SEC Filing Travere Therapeutics (TVTX) PT Raised to $65 at Guggenheim June 25, 2026 7:38 AM - StreetInsider Form 4 Travere Therapeutics, For: Jun 22 Filed by: Inrig Jula June 22, 2026 4:37 PM - SEC Filing Travere Therapeutics (TVTX) PT Raised to $61 at Wedbush June 22, 2026 8:09 AM - StreetInsider Form S-8 Travere Therapeutics, June 17, 2026 4:33 PM - SEC Filing Form 4 Travere Therapeutics, For: Jun 12 Filed by: Coughlin Timothy June 16, 2026 4:47 PM - SEC Filing Form 4 Travere Therapeutics, For: Jun 12 Filed by: Baynes Roy D. June 16, 2026 4:43 PM - SEC Filing Form 8-K Travere Therapeutics, For: Jun 12 June 16, 2026 4:35 PM - SEC Filing Travere Therapeutics names new R&D head ahead of 2027 retirement June 16, 2026 4:30 PM - StreetInsider Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027 June 16, 2026 4:30 PM - BizWire Travere Therapeutics (TVTX) PT Raised to $70 at Citi June 15, 2026 5:35 AM - StreetInsider Form 144 Travere Therapeutics, Filed by: Baynes Roy D. June 12, 2026 4:05 PM - SEC Filing Form 144 Travere Therapeutics, Filed by: Coughlin Timothy June 12, 2026 12:20 PM - SEC Filing Travere Therapeutics (TVTX) PT Raised to $65 at Wells Fargo June 12, 2026 6:33 AM - StreetInsider Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 11, 2026 5:00 PM - BizWire Full Article List